Publication:
Effect of antituberculous drugs on human polymorphonuclear leukocyte functions in vitro

Simple item page
dc.contributor.authorOKUYAN, BETÜL
dc.contributor.authorsOkuyan, B; Izzettin, FV; Sancar, M; Ertas, O; Cevikbas, A; Gurer, US
dc.date.accessioned2022-03-12T17:19:14Z
dc.date.available2022-03-12T17:19:14Z
dc.date.issued2005
dc.description.abstractThe aim of the study was to investigate antituberculous drugs effects on polymorphonuclear leukocyte (PMN) functions (phagocytic activity and intracellular killing activity) in vitro. PMNs obtained from healthy volunteers were incubated with antituberculous drugs (isoniazid [INH], rifampin [RIF], pyrazinamide [PZA], ethambutol [EMB], streptomycin [S], amikacin [A], ofloxacin [OFLX], prothionamide [PTH] and cycloserine [CyC]) and different combinations at therapeutic serum concentrations. Phagocytic activity of PMNs was significantly increased when compared with controls by PTH (p<0.001), A (p<0.001), OFLX (p<0.001), INH+RIF+S combination (p<0.01), A+OFLX combination (p<0.05), A+OFLX+CyC combination (p<0.01) and A+OFLX+CyC+PTH+EMB combination (p<0.01). Intracellular killing activity of PMNs was significantly increased by OFLX when compared with the control (p<0.05). No significant difference was observed in functions of PMN for other drugs when compared with control (p>0.05). Functions of PMN were significantly increased by OFLX when compared with A+OFLX combination (p<0.05). Phagocytic activity of PMNs was significantly increased by A+OFLX+CyC combination and A+OFLX+CyC+PTH+EMB combination when compared with A+OFLX+CyC+PTH combination and A+OFLX+CyC+PTH+PZA combination (p<0.05). No significant difference was found in functions of PMN between the other groups (p>0.05). In conclusion, some antituberculous drugs alone or in combination enhanced PMN functions, although in combination no additive or synergistic effects were detected. Moreover, none of the antituberculous drugs alone or in combination significantly decreased PMN functions. The drugs having adverse effects on immune functions would better be replaced with equally effective drugs or drug combinations having positive effects on PMN functions. (C) 2005 Published by Elsevier B.V.
dc.identifier.doi10.1016/j.intimp.2005.03.002
dc.identifier.issn1567-5769
dc.identifier.pubmed15914338
dc.identifier.urihttps://hdl.handle.net/11424/228077
dc.identifier.wosWOS:000229714300023
dc.language.isoeng
dc.publisherELSEVIER SCIENCE BV
dc.relation.ispartofINTERNATIONAL IMMUNOPHARMACOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectpolymorphonuclear leukocyte
dc.subjectantituberculous drugs
dc.subjectphagocytosis
dc.subjectintracellular killing
dc.subjectPULMONARY TUBERCULOSIS
dc.subjectAMINOGLYCOSIDE ANTIBIOTICS
dc.subjectPHAGOCYTE FUNCTIONS
dc.subjectNEUTROPHIL FUNCTION
dc.subjectAGENTS
dc.subjectINVITRO
dc.subjectCHEMILUMINESCENCE
dc.subjectSERUM
dc.titleEffect of antituberculous drugs on human polymorphonuclear leukocyte functions in vitro
dc.typearticle
dspace.entity.typePublication
local.avesis.idfc737b95-cf2c-422b-b3e8-7bad95348744
local.import.packageSS17
local.indexed.atWOS
local.indexed.atSCOPUS
local.journal.numberofpages6
oaire.citation.endPage1342
oaire.citation.issue7-8
oaire.citation.startPage1337
oaire.citation.titleINTERNATIONAL IMMUNOPHARMACOLOGY
oaire.citation.volume5
relation.isAuthorOfPublicationf6e7969a-ea61-403f-8772-1a8478556223
relation.isAuthorOfPublication.latestForDiscoveryf6e7969a-ea61-403f-8772-1a8478556223

Files

Collections

Research Outputs